Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
Jermaine Goveia1, Peter Stapor1, Peter Carmeliet2
1Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, Department of Oncology, University of Leuven, Leuven, Belgium Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center VIB, Leuven, Belgium.
Insights
Targeting endothelial cell (EC) metabolism offers a novel therapeutic strategy for diseases linked to abnormal blood vessel growth and EC dysfunction. This approach aims to reverse dysfunction and inhibit pathological angiogenesis by addressing metabolic alterations.
Area of Science:
- Vascular Biology
- Metabolic Research
- Pathology
Background:
- Endothelial cells (ECs) orchestrate blood vessel function.
- Pathological angiogenesis and EC dysfunction are hallmarks of various diseases.
- Current therapies for these conditions have limited efficacy.
Purpose of the Study:
- To review recent advancements in understanding EC-specific metabolic alterations in disease.
- To discuss potential metabolic targets for therapeutic intervention.
- To explore strategies for reversing EC dysfunction and inhibiting pathological angiogenesis.
Main Methods:
- Literature review of recent scientific findings.
- Analysis of EC-specific metabolic changes in disease contexts.
- Identification and discussion of potential therapeutic targets and strategies.
Main Results:
- Pathological angiogenesis and EC dysfunction are associated with EC-specific metabolic alterations.
- Targeting EC metabolism is an emerging therapeutic strategy.
- Metabolic interventions hold promise for treating cancer and cardiovascular diseases.
Conclusions:
- Understanding EC metabolism is crucial for developing effective treatments.
- Modulating EC metabolism can potentially reverse disease-associated dysfunction.
- Targeting EC metabolism represents a promising frontier in vascular disease therapy.
Abstract:
The endothelium is the orchestral conductor of blood vessel function. Pathological blood vessel formation (a process termed pathological angiogenesis) or the inability of endothelial cells (ECs) to perform their physiological function (a condition known as EC dysfunction) are defining features of various diseases. Therapeutic intervention to inhibit aberrant angiogenesis or ameliorate EC dysfunction could be beneficial in diseases such as cancer and cardiovascular disease, respectively, but current strategies have limited efficacy. Based on recent findings that pathological angiogenesis and EC dysfunction are accompanied by EC-specific metabolic alterations, targeting EC metabolism is emerging as a novel therapeutic strategy. Here, we review recent progress in our understanding of how EC metabolism is altered in disease and discuss potential metabolic targets and strategies to reverse EC dysfunction and inhibit pathological angiogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mechanism of Angiogenesis
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

